Can I read Catalyst Pharmaceuticals FDA Case Summary on EtoBox?

Catalyst Pharmaceuticals FDA Case Summary by TradeHawk is a document available to read on EtoBox.

What is Catalyst Pharmaceuticals FDA Case Summary about?

This document is a report and recommendations from a United States District Court regarding motions for summary judgment in a case between Catalyst Pharmaceuticals, Inc. and the FDA. It provides background on the regulatory framework regarding orphan drug designation and exclusivity. It describes that Catalyst received approval for its drug Firdapse to treat LEMS in adults, while Jacobus Pharmaceuticals sought approval for its similar drug Ruzurgi to treat LEMS in both adults and pediatric patients, which C

Author

TradeHawk

Language

EN